| 中文名称 |
Potassium clavulanate cellulose
|
| 英文名称 |
Potassium clavulanate cellulose
|
| 包装储存 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| 详情描述 |
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) 是克拉维酸钾和纤维素的混合物,是一种细菌 β-内酰胺酶 的抑制剂。克拉维酸钾 (Clavulanate potassium) 是克拉维酸 (Clavulanic acid) 的一种形式。克拉维酸钾能抵抗青霉素类和其他抗生素的细菌。克拉维酸钾与阿莫西林结合,可用于研究由细菌引起的不同感染,如鼻窦炎、肺炎、耳部感染、支气管炎、尿路感染、皮肤感染等。
|
| 产品详情 |
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) 是克拉维酸钾和纤维素的混合物,是一种细菌 β-内酰胺酶 的抑制剂。克拉维酸钾 (Clavulanate potassium) 是克拉维酸 (Clavulanic acid) 的一种形式。克拉维酸钾能抵抗青霉素类和其他抗生素的细菌。克拉维酸钾与阿莫西林结合,可用于研究由细菌引起的不同感染,如鼻窦炎、肺炎、耳部感染、支气管炎、尿路感染、皮肤感染等。
|
| 生物活性 |
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Clavulanate potassium is a form of Clavulanic acid. Clavulanate potassium fights bacteria that resistant to penicillins and other antibiotics. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.
|
| 性状 |
Solid
|
| IC50 & Target[1][2] |
β-lactam
|
| 体外研究(In Vitro) |
Clavulanate potassium (2 μg/mL) is susceptive to β-lactamase-positive and β-lactamase-negative Bacteroides spp. and Fusobacterium spp. with the combination of amoxicillin (4 μg/mL) and ticarcillin (64 μg/mL).Clavulanate potassium (16 μg/mL) inhibits B. intermedius , B. bivius , B. disiens , B. oris , B. buccae , B. buccalis and B. loeschei with MIC50 values of 8 μg/mL.Clavulanate potassium (16 μg/mL) inhibits B. melaninogenicus , B. oralis and F. varium with MIC50 values of 16 μg/mL.Clavulanate potassium (2 μg/mL) raises amoxicillin susceptibility rates for β-lactamase-positive Bacteroides species and fusobacteria from 41.3 to 90.8% and from 64.2 to 88.7%, respectively. has not independently confirme
|
| 体内研究(In Vivo) |
Clavulanate potassium (125 mg; 20 d) protects 75% of mice with experimental pneumonitis compared with no survivors in the control group. has not independently confirmed the accuracy of these methods. They are for reference only.
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| 参考文献 |
[1]. Appelbaum PC, et al. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50.[2]. Beale AS, et al. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis. J Antimicrob Chemother. 1991 May;2
|
| 溶解度数据 |
In Vitro: DMSO : 1 mg/mL (ultrasonic and warming and heat to 80°C)H2O : < 0.1 mg/mL (insoluble)
|
[1]. Appelbaum PC, et al. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50.[2]. Beale AS, et al. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis. J Antimicrob Chemother. 1991 May;2
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。